A recent study conducted by Northwestern faculty identified a novel therapeutic agent that has proven to be effective in treating metastatic breast cancer and brain metastases. The study was conducted by Feinberg Prof. Maciej Lesniak and established that metixene — a central nervous system small-molecule inhibitor drug — killed cancer cells in mice models of...